Showing results (21-30 of 362) with videos related to
Sort By:
Pageof 37
Cancer Research|November 1, 1982
In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II)S Seeber, R Osieka, C G Schmidt, et al.Archives of Toxicology|January 1, 1987
Positive correlation between decreased cellular uptake, NADPH-glutathione reductase activity and adriamycin resistance in Ehrlich ascites tumor linesM E Scheulen, H Hoensch, H Kappus, et al.Deutsche Medizinische Wochenschrift (1946)|February 6, 1976
[cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)]R Osieka, U Bruntsch, W M Gallmeier, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1984
Phase II evaluation of fractionated low and single high dose cisplatin in various tumorsR B Schilcher, M Wessels, N Niederle, et al.Deutsche Medizinische Wochenschrift (1946)|November 28, 1975
[Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)]U Bruntsch, R Osieka, W M GAllmeier, et al.Deutsche Medizinische Wochenschrift (1946)|August 6, 1976
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]R Osieka, U Bruntsch, W M Gallmeier, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1981
Autonomous cortisol secretion by a metastatic Leydig cell carcinoma associated with Klinefelter's syndromeK Knyrim, M Higi, D K Hossfeld, et al.British Journal of Cancer|April 1, 1985
Chemotherapy of metastatic seminomaJ Schuette, N Niederle, M E Scheulen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Enhancement of etoposide-induced cytotoxicity by cyclosporin AR Osieka, S Seeber, R Pannenbäcker, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1984
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumorsJ Schütte, N Niederle, B Grunenberg, et al.Pageof 37